neuro · clinical-trial
Selank
Heptapeptídeo nootrópico russo.
Status:clinical-trial
Updated:May 13, 2026
Contributors:2
Half-life
0.5 h
Routes
IN, SC
Typical dose
250–500 mcg
Mechanism of action
Modula GABA, dopamina e BDNF.
Reported applications
- · anxiolytic
- · cognitive
Frequently asked
What is Selank?
Heptapeptídeo nootrópico russo.
What is the half-life of Selank?
Reference half-life: approximately 0.5 hours. Individual pharmacokinetics may vary.
Is PX7 prescribing Selank?
No. PX7 is an educational reference and a community knowledge layer. It does not prescribe, sell, or recommend substances.
Explore the cluster
PX7 publishes educational and community-curated references on regenerative and longevity science. Nothing on this page is medical advice, prescription, or a recommendation to obtain or use any substance. Always consult a qualified clinician.